MGRX logo

MGRX
Mangoceuticals Inc

2,967
Mkt Cap
$8.51M
Volume
404,944.00
52W High
$2.75
52W Low
$0.162
PE Ratio
-0.31
MGRX Fundamentals
Price
$0.5037
Prev Close
$0.4957
Open
$0.5099
50D MA
$0.3867
Beta
0.97
Avg. Volume
630,616.25
EPS (Annual)
-$2.17
P/B
0.62
Rev/Employee
$152,007.00
$6.27
Loading...
Loading...
News
all
press releases
Mangoceuticals Stock Doubles After Texas Lawsuit
Mangoceuticals stock jumps despite no fresh news, as lawsuit dispute, TRT sales surge, and platform shift shape investor sentiment.read more...
News Placeholder
More News
News Placeholder
Regulatory Wins, Capital Flows, and Global Expansion Drive Market Momentum
A wave of regulatory clarity, strategic financing, and global expansion is reshaping pockets of the market, with companies across biotech, mobility, and emerging healthcare infrastructure positioning for outsized growth. $MGRX, $TOVX, $ZYBT, $FFAI, $TGNT
News Placeholder
Penny Stocks To Follow Now - February 21st
Rackspace Technology, Cardio Diagnostics, Mana Capital Acquisition, Mangoceuticals, and BigBear.ai are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny...
News Placeholder
Penny Stocks To Watch Today - February 20th
Rackspace Technology, Cardio Diagnostics, and Mangoceuticals are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are very low-priced shares...
News Placeholder
Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?
Shares of Mangoceuticals are trading sharply higher Friday afternoon after the company reported momentum for its $99-per-month TRT program.read more...
News Placeholder
Mangoceuticals Announces Solana-Focused $100M Digital Asset Treasury, Sees ‘Compelling, Non-Dilutive Returns’
Mangoceuticals had also recently filed a trademark application for “MULTI-DAT” with the United States Patent and Trademark Office in a bid to expand into the digital asset space.
News Placeholder
Insider Selling: Mangoceuticals (NASDAQ:MGRX) CFO Sells 10,000 Shares of Stock
Mangoceuticals, Inc. (NASDAQ:MGRX - Get Free Report) CFO Eugene Johnston sold 10,000 shares of Mangoceuticals stock in a transaction that occurred on Friday, December 5th. The shares were sold at an...
News Placeholder
Insider Selling: Mangoceuticals (NASDAQ:MGRX) Director Sells 125,000 Shares of Stock
Mangoceuticals, Inc. (NASDAQ:MGRX - Get Free Report) Director Alex Hamilton sold 125,000 shares of the stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of...
News Placeholder
Why Did Mangoceuticals Shares Rise Today?
The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available